|
1
|
Bray F, Ferlay J, Soerjomataram I, Siegel
RL, Torre LA and Jemal A: Global cancer statistics 2018: GLOBOCAN
estimates of incidence and mortality worldwide for 36 cancers in
185 countries. CA Cancer J Clin. 68:394–424. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Bosetti C, Turati F and La Vecchia C:
Hepatocellular carcinoma epidemiology. Best Pract Res Clin
Gastroenterol. 28:753–770. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Fan JH, Wang JB, Jiang Y, Xiang W, Liang
H, Wei WQ, Qiao YL and Boffetta P: Attributable causes of liver
cancer mortality and incidence in China. Asian Pac J Cancer Prev.
14:7251–7256. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
de Martel C, Maucort-Boulch D, Plummer M
and Franceschi S: World-wide relative contribution of hepatitis B
and C viruses in hepatocellular carcinoma. Hepatology.
62:1190–1200. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Balogh J, Victor D III, Asham EH,
Burroughs SG, Boktour M, Saharia A, Li X, Ghobrial RM and Monsour
HP Jr: Hepatocellular carcinoma: A review. J Hepatocell Carcinoma.
3:41–53. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Anastas JN and Moon RT: WNT signalling
pathways as therapeutic targets in cancer. Nat Rev Cancer.
13:11–26. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Cheng R, Sun B, Liu Z, Zhao X, Qi L, Li Y
and Gu Q: Wnt5a suppresses colon cancer by inhibiting cell
proliferation and epithelial-mesenchymal transition. J Cell
Physiol. 229:1908–1917. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Shiah SG, Hsiao JR, Chang WM, Chen YW, Jin
YT, Wong TY, Huang JS, Tsai ST, Hsu YM, Chou ST, et al:
Downregulated miR329 and miR410 promote the proliferation and
invasion of oral squamous cell carcinoma by targeting Wnt-7b.
Cancer Res. 74:7560–7572. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Chen X, Jia C, Jia C, Jin X and Gu X:
MicroRNA-374a inhibits aggressive tumor biological behavior in
bladder carcinoma by suppressing Wnt/β-catenin signaling. Cell
Physiol Biochem. 48:815–826. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Yamamoto H, Oue N, Sato A, Hasegawa Y,
Yamamoto H, Matsubara A, Yasui W and Kikuchi A: Wnt5a signaling is
involved in the aggressiveness of prostate cancer and expression of
metalloproteinase. Oncogene. 29:2036–2046. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Zhang W, Sun Z, Su L, Wang F, Jiang Y, Yu
D, Zhang F, Sun Z and Liang W: miRNA-185 serves as a prognostic
factor and suppresses migration and invasion through Wnt1 in colon
cancer. Eur J Pharmacol. 825:75–84. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Bo H, Zhang S, Gao L, Chen Y, Zhang J,
Chang X and Zhu M: Upregulation of Wnt5a promotes
epithelial-to-mesenchymal transition and metastasis of pancreatic
cancer cells. BMC Cancer. 13:4962013. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Wang H, Fan L, Xia X, Rao Y, Ma Q, Yang J,
Lu Y, Wang C and Huang X: Silencing Wnt2B by siRNA interference
inhibits metastasis and enhances chemotherapy sensitivity in
ovarian cancer. Int J Gynecol Cancer. 22:755–761. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Webster MR, Xu M, Kinzler KA, Kaur A,
Appleton J, O'Connell MP, Marchbank K, Valiga A, Dang VM, Perego M,
et al: Wnt5A promotes an adaptive, senescent-like stress response,
while continuing to drive invasion in melanoma cells. Pigment Cell
Melanoma Res. 28:184–195. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Chen PH, Liu AJ, Ho KH, Chiu YT, Anne Lin
ZH, Lee YT, Shih CM and Chen KC: microRNA-199a/b-5p enhance
imatinib efficacy via repressing WNT2 signaling-mediated protective
autophagy in imatinib-resistant chronic myeloid leukemia cells.
Chem Biol Interact. 291:144–151. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Fu L, Zhang C, Zhang LY, Dong SS, Lu LH,
Chen J, Dai Y, Li Y, Kong KL, Kwong DL and Guan XY: Wnt2 secreted
by tumour fibroblasts promotes tumour progression in oesophageal
cancer by activation of the Wnt/β-catenin signalling pathway. Gut.
60:1635–1643. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Roessler S, Jia HL, Budhu A, Forgues M, Ye
QH, Lee JS, Thorgeirsson SS, Sun Z, Tang ZY, Qin LX and Wang XW: A
unique metastasis gene signature enables prediction of tumor
relapse in early-stage hepatocellular carcinoma patients. Cancer
Res. 70:10202–10212. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Roessler S, Long EL, Budhu A, Chen Y, Zhao
X, Ji J, Walker R, Jia HL, Ye QH, Qin LX, et al: Integrative
genomic identification of genes on 8p associated with
hepatocellular carcinoma progression and patient survival.
Gastroenterology. 142:957–966.e12. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Liao X, Liu X, Yang C, Wang X, Yu T, Han
C, Huang K, Zhu G, Su H, Qin W, et al: Distinct diagnostic and
prognostic values of minichromosome maintenance gene expression in
patients with hepatocellular carcinoma. J Cancer. 9:2357–2373.
2018. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Anders S and Huber W: Differential
expression analysis for sequence count data. Genome Biol.
11:R1062010. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Huang da W, Sherman BT and Lempicki RA:
Systematic and integrative analysis of large gene lists using DAVID
bioinformatics resources. Nat Protoc. 4:44–57. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Maere S, Heymans K and Kuiper M: BiNGO: A
Cytoscape plugin to assess overrepresentation of gene ontology
categories in biological networks. Bioinformatics. 21:3448–3449.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Mostafavi S, Ray D, Warde-Farley D,
Grouios C and Morris Q: GeneMANIA: A real-time multiple association
network integration algorithm for predicting gene function. Genome
Biol. 9 (Suppl 1):S42008. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
von Mering C, Huynen M, Jaeggi D, Schmidt
S, Bork P and Snel B: STRING: A database of predicted functional
associations between proteins. Nucleic Acids Res. 31:258–261. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Szklarczyk D, Morris JH, Cook H, Kuhn M,
Wyder S, Simonovic M, Santos A, Doncheva NT, Roth A, Bork P, et al:
The STRING database in 2017: Quality-controlled protein-protein
association networks, made broadly accessible. Nucleic Acids Res.
45:D362–D368. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Shaul YD, Yuan B, Thiru P, Nutter-Upham A,
McCallum S, Lanzkron C, Bell GW and Sabatini DM: MERAV: A tool for
comparing gene expression across human tissues and cell types.
Nucleic Acids Res. 44:D560–566. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Alonso L and Fuchs E: Stem cells in the
skin: Waste not, Wnt not. Genes Dev. 17:1189–1200. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Monga SP: Role of Wnt/β-catenin signaling
in liver metabolism and cancer. Int J Biochem Cell Biol.
43:1021–1029. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Beers MF and Morrisey EE: The three R's of
lung health and disease: Repair, remodeling, and regeneration. J
Clin Invest. 121:2065–2073. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Nemeth MJ, Mak KK, Yang Y and Bodine DM:
Beta-Catenin expression in the bone marrow microenvironment is
required for long-term maintenance of primitive hematopoietic
cells. Stem Cells. 27:1109–1119. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Malhotra S and Kincade PW: Wnt-related
molecules and signaling pathway equilibrium in hematopoiesis. Cell
Stem Cell. 4:27–36. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Inestrosa NC and Arenas E: Emerging roles
of Wnts in the adult nervous system. Nat Rev Neurosci. 11:77–86.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Polakis P: Drugging Wnt signalling in
cancer. EMBO J. 31:2737–2746. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Herr P, Hausmann G and Basler K: WNT
secretion and signalling in human disease. Trends Mol Med.
18:483–493. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Kikuchi A and Yamamoto H: Tumor formation
due to abnormalities in the beta-catenin-independent pathway of Wnt
signaling. Cancer Sci. 99:202–208. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Day TF, Guo X, Garrett-Beal L and Yang Y:
Wnt/beta-catenin signaling in mesenchymal progenitors controls
osteoblast and chondrocyte differentiation during vertebrate
skeletogenesis. Dev Cell. 8:739–750. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Glass DA II, Bialek P, Ahn JD, Starbuck M,
Patel MS, Clevers H, Taketo MM, Long F, McMahon AP, Lang RA and
Karsenty G: Canonical Wnt signaling in differentiated osteoblasts
controls osteoclast differentiation. Dev Cell. 8:751–764. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Königshoff M, Balsara N, Pfaff EM, Kramer
M, Chrobak I, Seeger W and Eickelberg O: Functional Wnt signaling
is increased in idiopathic pulmonary fibrosis. PLoS One.
3:e21422008. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Henderson WR Jr, Chi EY, Ye X, Nguyen C,
Tien YT, Zhou B, Borok Z, Knight DA and Kahn M: Inhibition of
Wnt/beta-catenin/CREB binding protein (CBP) signaling reverses
pulmonary fibrosis. Proc Natl Acad Sci USA. 107:14309–14314. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Akhmetshina A, Palumbo K, Dees C, Bergmann
C, Venalis P, Zerr P, Horn A, Kireva T, Beyer C, Zwerina J, et al:
Activation of canonical Wnt signalling is required for
TGF-β-mediated fibrosis. Nat Commun. 3:7352012. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Sen M, Lauterbach K, El-Gabalawy H,
Firestein GS, Corr M and Carson DA: Expression and function of
wingless and frizzled homologs in rheumatoid arthritis. Proc Natl
Acad Sci USA. 97:2791–2796. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Nakamura Y, Nawata M and Wakitani S:
Expression profiles and functional analyses of Wnt-related genes in
human joint disorders. Am J Pathol. 167:97–105. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Keerthivasan S, Aghajani K, Dose M,
Molinero L, Khan MW, Venkateswaran V, Weber C, Emmanuel AO, Sun T,
Bentrem DJ, et al: β-catenin promotes colitis and colon cancer
through imprinting of proinflammatory properties in T cells. Sci
Transl Med. 6:225ra2282014. View Article : Google Scholar
|
|
44
|
Kalkman HO: A review of the evidence for
the canonical Wnt pathway in autism spectrum disorders. Mol Autism.
3:102012. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
De Ferrari GV, Papassotiropoulos A,
Biechele T, Wavrant De-Vrieze F, Avila ME, Major MB, Myers A, Sáez
K, Henríquez JP, Zhao A, et al: Common genetic variation within the
low-density lipoprotein receptor-related protein 6 and late-onset
Alzheimer's disease. Proc Natl Acad Sci USA. 104:9434–9439. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
46
|
García-Jiménez C: Wnt and incretin
connections. Vitam Horm. 84:355–387. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Welters HJ and Kulkarni RN: Wnt signaling:
Relevance to beta-cell biology and diabetes. Trends Endocrinol
Metab. 19:349–355. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Grant SF, Thorleifsson G, Reynisdottir I,
Benediktsson R, Manolescu A, Sainz J, Helgason A, Stefansson H,
Emilsson V, Helgadottir A, et al: Variant of transcription factor
7-like 2 (TCF7L2) gene confers risk of type 2 diabetes. Nat Genet.
38:320–323. 2006. View
Article : Google Scholar : PubMed/NCBI
|
|
49
|
Kurayoshi M, Oue N, Yamamoto H, Kishida M,
Inoue A, Asahara T, Yasui W and Kikuchi A: Expression of Wnt-5a is
correlated with aggressiveness of gastric cancer by stimulating
cell migration and invasion. Cancer Res. 66:10439–10448. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Schwartz AL, Malgor R, Dickerson E,
Weeraratna AT, Slominski A, Wortsman J, Harii N, Kohn AD, Moon RT,
Schwartz FL, et al: Phenylmethimazole decreases Toll-like receptor
3 and noncanonical Wnt5a expression in pancreatic cancer and
melanoma together with tumor cell growth and migration. Clin Cancer
Res. 15:4114–4122. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Li X, Placencio V, Iturregui JM, Uwamariya
C, Sharif-Afshar AR, Koyama T, Hayward SW and Bhowmick NA: Prostate
tumor progression is mediated by a paracrine TGF-beta/Wnt3a
signaling axis. Oncogene. 27:7118–7130. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Yoshioka S, King ML, Ran S, Okuda H,
MacLean JA II, McAsey ME, Sugino N, Brard L, Watabe K and Hayashi
K: WNT7A regulates tumor growth and progression in ovarian cancer
through the WNT/beta-catenin pathway. Mol Cancer Res. 10:469–482.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Bitler BG, Nicodemus JP, Li H, Cai Q, Wu
H, Hua X, Li T, Birrer MJ, Godwin AK, Cairns P and Zhang R: Wnt5a
suppresses epithelial ovarian cancer by promoting cellular
senescence. Cancer Res. 71:6184–6194. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
54
|
Ochoa-Hernández AB, Ramos-Solano M,
Meza-Canales ID, García-Castro B, Rosales-Reynoso MA, Rosales-Aviña
JA, Barrera-Chairez E, Ortíz-Lazareno PC, Hernández-Flores G,
Bravo-Cuellar A, et al: Peripheral T-lymphocytes express WNT7A and
its restoration in leukemia-derived lymphoblasts inhibits cell
proliferation. BMC Cancer. 12:602012. View Article : Google Scholar : PubMed/NCBI
|
|
55
|
Sin MLY, Mach KE, Sinha R, Wu F, Trivedi
DR, Altobelli E, Jensen KC, Sahoo D, Lu Y and Liao JC: Deep
sequencing of urinary RNAs for bladder cancer molecular
diagnostics. Clin Cancer Res. 23:3700–3710. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
56
|
Jiang K, Li S, Li L, Wang X, Gu Y and Jin
Z: WNT6 is an effective marker for osteosarcoma diagnosis and
prognosis. Medicine (Baltimore). 97:e130112018. View Article : Google Scholar : PubMed/NCBI
|
|
57
|
Xu X, Sun PL, Li JZ, Jheon S, Lee CT and
Chung JH: Aberrant Wnt1/β-catenin expression is an independent poor
prognostic marker of non-small cell lung cancer after surgery. J
Thorac Oncol. 6:716–724. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
58
|
Shi Q, Liu H, Han P, Li C, Wang Y, Wu W,
Zhu D, Amos CI, Fang S, Lee JE, et al: Genetic variants in WNT2B
and BTRC predict melanoma survival. J Invest Dermatol.
137:1749–1756. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
59
|
Geng M, Cao YC, Chen YJ, Jiang H, Bi LQ
and Liu XH: Loss of Wnt5a and Ror2 protein in hepatocellular
carcinoma associated with poor prognosis. World J Gastroenterol.
18:1328–1338. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
60
|
Wu ZC, Xiong L, Wang LX, Miao XY, Liu ZR,
Li DQ, Zou Q, Liu KJ, Zhao H and Yang ZL: Comparative study of ROR2
and WNT5a expression in squamous/adenosquamous carcinoma and
adenocarcinoma of the gallbladder. World J Gastroenterol.
23:2601–2612. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
61
|
Lee SE, Lim SD, Kang SY, Suh SB and Suh
YL: Prognostic significance of Ror2 and Wnt5a expression in
medulloblastoma. Brain Pathol. 23:445–453. 2013. View Article : Google Scholar : PubMed/NCBI
|
